TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Prepaid Expense of $814.20 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2014-06-30 was $1.28M.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2014-03-31 was -$462.86K, a 510.97% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2013-09-30 was $362.75K, a 894.85% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2013-06-30 was -$16.56K, a 122.89% decline year-over-year.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 25 month | Increase (Decrease) in Prepaid Expense 28 month | Increase (Decrease) in Prepaid Expense 31 month | Increase (Decrease) in Prepaid Expense 31 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $814.20K 10-Q · filed 2014-08-14 | ||||||||
| 2014-03-31 | -$462.86K 10-Q · filed 2014-05-15 | |||||||||
| 2013-09-30 | $362.75K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2015-07-09 | $346.19K derived: sum of 2 quarters · filed 2015-07-09 | $458.82K 10-Q/A · filed 2015-07-09 | -$458.82K 10-Q · filed 2013-11-13 | $480.65K 10-Q/A · filed 2015-07-09 | -$480.65K 10-Q · filed 2013-11-13 | ||||
| 2013-06-30 | -$16.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $96.06K 10-Q · filed 2014-08-14 | -$96.06K 10-Q · filed 2013-09-16 | -$117.89K 10-Q · filed 2013-09-16 | ||||||
| 2013-03-31 | $112.63K 10-Q · filed 2014-05-15 | -$112.63K 10-Q · filed 2013-07-24 | -$134.46K 10-Q/A · filed 2013-09-16 | |||||||
| 2012-09-30 | $36.46K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2015-07-09 | $108.82K derived: sum of 2 quarters · filed 2015-07-09 | $30.43K 10-Q/A · filed 2015-07-09 | -$30.43K 10-Q · filed 2013-11-13 | ||||||
| 2012-06-30 | $72.36K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-09-16 | -$6.03K 10-Q · filed 2013-09-16 | ||||||||
| 2012-03-31 | -$78.39K 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |